SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-128936
Filing Date
2023-05-01
Accepted
2023-05-01 09:00:52
Documents
9
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A d484792ddef14a.htm DEF 14A 691369
2 GRAPHIC g484792g45r59.jpg GRAPHIC 5898
3 GRAPHIC g484792g58u36.jpg GRAPHIC 33770
4 GRAPHIC g484792g60k43.jpg GRAPHIC 2040
5 GRAPHIC g484792g95b94.jpg GRAPHIC 1662
6 GRAPHIC g484792sp01f.jpg GRAPHIC 1174
7 GRAPHIC g484792sp1e.jpg GRAPHIC 1308
8 GRAPHIC g484792sp2.jpg GRAPHIC 1021
9 GRAPHIC g484792sp2a.jpg GRAPHIC 972
  Complete submission text file 0001193125-23-128936.txt   755630
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38914 | Film No.: 23870504
SIC: 2834 Pharmaceutical Preparations